These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 15464036)
1. TRPV1 and the gut: from a tasty receptor for a painful vanilloid to a key player in hyperalgesia. Holzer P Eur J Pharmacol; 2004 Oct; 500(1-3):231-41. PubMed ID: 15464036 [TBL] [Abstract][Full Text] [Related]
2. Capsaicin (TRPV1 Agonist) therapy for pain relief: farewell or revival? Knotkova H; Pappagallo M; Szallasi A Clin J Pain; 2008 Feb; 24(2):142-54. PubMed ID: 18209521 [TBL] [Abstract][Full Text] [Related]
3. Forty years in capsaicin research for sensory pharmacology and physiology. Szolcsányi J Neuropeptides; 2004 Dec; 38(6):377-84. PubMed ID: 15567473 [TBL] [Abstract][Full Text] [Related]
4. (R)-(5-tert-butyl-2,3-dihydro-1H-inden-1-yl)-3-(1H-indazol-4-yl)-urea (ABT-102) blocks polymodal activation of transient receptor potential vanilloid 1 receptors in vitro and heat-evoked firing of spinal dorsal horn neurons in vivo. Surowy CS; Neelands TR; Bianchi BR; McGaraughty S; El Kouhen R; Han P; Chu KL; McDonald HA; Vos M; Niforatos W; Bayburt EK; Gomtsyan A; Lee CH; Honore P; Sullivan JP; Jarvis MF; Faltynek CR J Pharmacol Exp Ther; 2008 Sep; 326(3):879-88. PubMed ID: 18515644 [TBL] [Abstract][Full Text] [Related]
5. Cloning and pharmacological characterization of mouse TRPV1. Correll CC; Phelps PT; Anthes JC; Umland S; Greenfeder S Neurosci Lett; 2004 Nov; 370(1):55-60. PubMed ID: 15489017 [TBL] [Abstract][Full Text] [Related]
6. Transient receptor potential vanilloid 1 mediates hyperalgesia and is up-regulated in rats with chronic pancreatitis. Xu GY; Winston JH; Shenoy M; Yin H; Pendyala S; Pasricha PJ Gastroenterology; 2007 Oct; 133(4):1282-92. PubMed ID: 17698068 [TBL] [Abstract][Full Text] [Related]
7. Vanilloid receptor TRPV1 is not activated by vanilloids applied intracellularly. Vyklický L; Lyfenko A; Kuffler DP; Vlachová V Neuroreport; 2003 May; 14(7):1061-5. PubMed ID: 12802203 [TBL] [Abstract][Full Text] [Related]
8. Role of transient receptor potential vanilloid 1 receptors in adjuvant-induced chronic arthritis: in vivo study using gene-deficient mice. Szabó A; Helyes Z; Sándor K; Bite A; Pintér E; Németh J; Bánvölgyi A; Bölcskei K; Elekes K; Szolcsányi J J Pharmacol Exp Ther; 2005 Jul; 314(1):111-9. PubMed ID: 15831443 [TBL] [Abstract][Full Text] [Related]
9. Regulation mechanisms of vanilloid receptors. Tominaga M; Numazaki M; Iida T; Moriyama T; Togashi K; Higashi T; Murayama N; Tominaga T Novartis Found Symp; 2004; 261():4-12; discussion 12-8, 47-54. PubMed ID: 15469041 [TBL] [Abstract][Full Text] [Related]
10. A-425619 [1-isoquinolin-5-yl-3-(4-trifluoromethyl-benzyl)-urea], a novel transient receptor potential type V1 receptor antagonist, relieves pathophysiological pain associated with inflammation and tissue injury in rats. Honore P; Wismer CT; Mikusa J; Zhu CZ; Zhong C; Gauvin DM; Gomtsyan A; El Kouhen R; Lee CH; Marsh K; Sullivan JP; Faltynek CR; Jarvis MF J Pharmacol Exp Ther; 2005 Jul; 314(1):410-21. PubMed ID: 15837818 [TBL] [Abstract][Full Text] [Related]
12. Activation and sensitisation of the vanilloid receptor: role in gastrointestinal inflammation and function. Geppetti P; Trevisani M Br J Pharmacol; 2004 Apr; 141(8):1313-20. PubMed ID: 15051629 [TBL] [Abstract][Full Text] [Related]
13. RNA interference-mediated knock-down of transient receptor potential vanilloid 1 prevents forepaw inflammatory hyperalgesia in rat. Kasama S; Kawakubo M; Suzuki T; Nishizawa T; Ishida A; Nakayama J Eur J Neurosci; 2007 May; 25(10):2956-63. PubMed ID: 17509082 [TBL] [Abstract][Full Text] [Related]
14. The role of the vanilloid (capsaicin) receptor (TRPV1) in physiology and pathology. Nagy I; Sántha P; Jancsó G; Urbán L Eur J Pharmacol; 2004 Oct; 500(1-3):351-69. PubMed ID: 15464045 [TBL] [Abstract][Full Text] [Related]
15. Contribution of transient receptor potential vanilloid subfamily 1 to endothelin-1-induced thermal hyperalgesia. Kawamata T; Ji W; Yamamoto J; Niiyama Y; Furuse S; Namiki A Neuroscience; 2008 Jun; 154(3):1067-76. PubMed ID: 18495351 [TBL] [Abstract][Full Text] [Related]
16. A-425619 [1-isoquinolin-5-yl-3-(4-trifluoromethyl-benzyl)-urea], a novel and selective transient receptor potential type V1 receptor antagonist, blocks channel activation by vanilloids, heat, and acid. El Kouhen R; Surowy CS; Bianchi BR; Neelands TR; McDonald HA; Niforatos W; Gomtsyan A; Lee CH; Honore P; Sullivan JP; Jarvis MF; Faltynek CR J Pharmacol Exp Ther; 2005 Jul; 314(1):400-9. PubMed ID: 15837819 [TBL] [Abstract][Full Text] [Related]
17. Block of native and cloned vanilloid receptor 1 (TRPV1) by aminoglycoside antibiotics. Raisinghani M; Premkumar LS Pain; 2005 Jan; 113(1-2):123-33. PubMed ID: 15621372 [TBL] [Abstract][Full Text] [Related]
18. Molecular cloning, functional characterization of the porcine transient receptor potential V1 (pTRPV1) and pharmacological comparison with endogenous pTRPV1. Ohta T; Komatsu R; Imagawa T; Otsuguro K; Ito S Biochem Pharmacol; 2005 Dec; 71(1-2):173-87. PubMed ID: 16288992 [TBL] [Abstract][Full Text] [Related]